Japan’s Ministry of Health, Labor and Welfare (MHLW) on March 5 unveiled the revised NHI prices for drugs subject to…
REGULATORY
Ryukaikon Members Hail High Price Settlements, but Fret over Fallout from Penalty Fee Cuts
Many members of the health ministry’s council for the improvement of ethical drug distribution agreed on December 9 that a new fee cut rule implemented in April to curb lengthy price negotiations worked more or less, but some called for…
To read the full story
Related Article
- No Progress for Wholesalers’ Negative Primary Margin on Sales, Single-Product, Single-Price Deals Stagnant: Ryukaikon
June 19, 2015
- Wholesalers’ Negative Primary Margin on Sales Widens Slightly in First Half of FY2014: Ryukaikon
December 11, 2014
- Annual NHI Price Cuts Draw Fire from All Sides at Ryukaikon Council
December 10, 2014
Related LEXICON
-
Medical Fee Cut Rule for Low Price Settlement Rates, Penalty Fee Cuts for Low Price Settlement Rates未妥結減算ルールMay 9, 2014
-
(Sales) price settlement rate（納入価格）妥結率October 25, 2010
REGULATORY
- Pipe Damage Causes Water Leak at Sawai Plant after Quake: MHLW
July 30, 2026
- MHLW Urges Stable Supply of Drugs after Kumamoto Earthquake
July 30, 2026
- Kumamoto Quake Hits 46 Medical Facilities; No Pharma Damage Yet: MHLW
July 29, 2026
- Japan Shifts Mo-99 Supply Strategy toward Stronger Global Procurement: Panel
July 29, 2026
- 3 Label Expansions Get NHI Coverage on Public Knowledge Pathway
July 29, 2026
Adeno-associated virus (AAV) gene therapies have long been viewed as carrying only a minimal risk of insertional mutagenesis — a…
Let’s face it: in today’s world, changing jobs is a normal part of a successful career. But if it’s so normal, why does it feel so hard? For many people, the idea of leaving their current role brings a heavy…
Japan’s Central Social Insurance Medical Council (Chuikyo) on November 5 approved the reimbursement listing for a slate of new medicines,…
The Japanese government on March 7 announced new NHI prices to be applied in the FY2025 drug price revision, revealing…
The Japanese government approved a bill to amend the Pharmaceuticals and Medical Devices (PMD) Act at its Cabinet meeting on…
Japan’s health ministry doled out regulatory approvals for a throng of new medicines on December 27 including Eli Lilly’s obesity…
Japan’s all-important reimbursement policy panel on December 20 approved an outline of drug pricing reforms for FY2024, which enshrines a…